Moneycontrol PRO
Open App

Stocks to Watch Today | JSW Steel, AstraZeneca Pharma, Tejas Networks, and others in news today

Stocks to Watch: Check out the companies making headlines before the opening bell.

August 22, 2022 / 06:13 AM IST
AstraZeneca Pharma India: AstraZeneca Pharma receives import & market permission from DCGI for Olaparib film-coated tablets. The pharma company has received import and market permission in Form CT-20, the subsequent new drug approval, from the Drugs Controller General of India for Olaparib film-coated tablets. With this approval, Olaparib film-coated tablets 100 mg and 150 mg is additionally indicated as a monotherapy for the adjuvant treatment of adult patients with BRCA-mutated HER2- negative high risk early breast cancer who have previously been treated with neoadjuvant or adjuvant chemotherapy.
AstraZeneca Pharma India: The pharma company has received import and market permission in Form CT-20, the subsequent new drug approval, from the Drugs Controller General of India for Olaparib film-coated tablets. With this approval, Olaparib film-coated tablets of 100mg and 150mg can be indicated as a monotherapy for the adjuvant treatment of adult patients with BRCA-mutated HER2- negative high risk early breast cancer who have previously been treated with neoadjuvant or adjuvant chemotherapy.
Tejas Networks: Tejas Networks increases stake in Saankhya Labs to 64.4% now. The company has acquired the remaining 93,571 equity shares in Saankhya Labs at a price of Rs 454.19 per share by paying Rs 4.25 crore through secondary purchase. With the said transaction, it has acquired entire 62,51,496 equity shares or 64.4% stake in Saankhya, for Rs 283.94 crore, on a fully diluted basis.
Tejas Networks: The company has acquired the remaining 93,571 equity shares in Saankhya Labs at a price of Rs 454.19 per share by paying Rs 4.25 crore through secondary purchase. With the said transaction, it has acquired the entire 62,51,496 equity shares or 64.4 percent stake in Saankhya, for Rs 283.94 crore, on a fully diluted basis.
Central Bank of India: Central Bank of India signs strategic co-lending partnership with Incred Financial Services to MSME loans. The public sector bank has entered into a strategic co-lending partnership with Incred Financial Services to offer loans to MSME borrowers at competitive rates. The participation by both the entities in this co-lending arrangement will result in greater expansion of portfolio by Central Bank of India and Incred Financial Services.
Central Bank of India: The public sector bank has entered into a strategic co-lending partnership with Incred Financial Services to offer loans to MSME borrowers at competitive rates. Participation by both the entities in this co-lending arrangement will result in greater expansion of portfolio by Central Bank of India and Incred Financial Services.
Shilpa Medicare: Shilpa Medicare arm completes human clinical studies of high concentration biosimilar Adalimumab. The subsidiary Shilpa Biologicals (SBPL) has successfully completed the phase 3 human clinical studies of its first biosimilar, the 100mg/ml high concentration (HC) Adalimumab biosimilar. The company has submitted the dossier to the CDSCO for review and grant of marketing or manufacturing license - a first in India. The drug is expected to cater to several diseases including rheumatoid arthritis, plaque psoriasis, and Ulcerative Colitis.
Shilpa Medicare: The subsidiary Shilpa Biologicals (SBPL) has successfully completed the phase 3 human clinical studies of its first biosimilar, the 100mg/ml high concentration (HC) Adalimumab biosimilar. The company has submitted the dossier to the CDSCO for review and grant of marketing or manufacturing license - a first in India. The drug is expected to cater to diseases such as rheumatoid arthritis, plaque psoriasis, and Ulcerative Colitis.
Oriental Hotels: Nippon Life India Trustee cuts stake in Oriental Hotels. Nippon Life India Trustee offloaded 1.95 lakh equity shares or 0.1% stake in the company via open market transactions. With this, its shareholding in the company reduced to 3.1687%, down from 3.2783% earlier.
Oriental Hotels: Nippon Life India Trustee offloaded 1.95 lakh equity shares or 0.1 percent stake in the company via open market transactions. With this, its shareholding in the company reduced to 3.1687 percent, down from 3.2783 percent earlier.
Indrayani Biotech: Indrayani Biotech bags contract of food services from Indian Institute of Technology, Roorkee. The food and hospitality division of the company has bagged an order from Indian Institute of Technology, Roorkee. The scope of work includes preparation and supply of food items to 5 of the 8 different Messes from August 20, 2022 to August 20, 2023. The contract is worth of Rs 12 crore per annum.
Indrayani Biotech: The food and hospitality division of the company has bagged an order from Indian Institute of Technology, Roorkee. The scope of work includes preparation and supply of food items to five of the eight different Messes from August 20, 2022 to August 20, 2023. The contract is worth of Rs 12 crore per annum.
IIFL Finance: CDC Group Plc exits IIFL Finance by selling entire shareholding. Morgan Stanley Asia Singapore Pte acquired 35 lakh equity shares in the company via open market transactions, at an average price of Rs 334.95 per share. However, CDC Group Plc sold 1.35 crore equity shares in the company at an average price of Rs 335.64 per share.
IIFL Finance: Morgan Stanley Asia Singapore Pte acquired 35 lakh equity shares in the company via open market transactions, at an average price of Rs 334.95 per share. However, CDC Group Plc sold 1.35 crore equity shares in the company at an average price of Rs 335.64 per share.
Mrs Bectors Food Specialities: Bajaj Holdings and Investment offloads nearly half of its stake in Mrs Bectors Food Specialities. Bajaj Holdings and Investment offloaded 3,22,176 equity shares in the company at an average price of Rs 360.06 per share.
Mrs Bectors Food Specialities: Bajaj Holdings and Investment offloaded 3,22,176 equity shares in the company at an average price of Rs 360.06 per share.
Repco Home Finance: UK-based AMC Omnis Global Emerging Markets Equity Opportunities Fund buys 4.76 lakh shares in Repco Home Finance. UK-based asset management firm Omnis Portfolio Investments Icvc-omnis Global Emerging Markets Equity Opportunities Fund bought 4,76,998 equity shares in the company at an average price of Rs 232.4 per share.
Repco Home Finance: The UK-based asset management firm Omnis Portfolio Investments Icvc-omnis Global Emerging Markets Equity Opportunities Fund bought 4,76,998 equity shares in the company at an average price of Rs 232.4 per share.
Computer Age Management Services: Promoter offloads 3.79% stake in Computer Age Management Services. Great Terrain Investment sold 18,55,870 equity shares or 3.79% stake in the company at an average price of Rs 2,306.18 per share.
Computer Age Management Services: Great Terrain Investment sold 18,55,870 equity shares or 3.79 percent stake in the company at an average price of Rs 2,306.18 per share.
Rama Steel Tubes: Investor Sixteenth Street Asian Gems Fund picks additional stake in Rama Steel Tubes. Sixteenth Street Asian Gems Fund bought additional 2.25 lakh equity shares in the company at an average price of Rs 568 per share.
Rama Steel Tubes: Sixteenth Street Asian Gems Fund bought additional 2.25 lakh equity shares in the company at an average price of Rs 568 per share.
Moneycontrol News
first published: Aug 22, 2022 06:13 am
Sections
ISO 27001 - BSI Assurance Mark